Drugs / CMV specific adoptive t-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02982902 | May 2020 → Aug 2027 expected | cytomegalovirus infection, disease related to hematopoietic stem cell transplant | Mari Dallas | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMV specific adoptive t-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02982902 ↗ |
| Modality | Cell therapy | “a specific type of cell-based immunotherapy” NCT02982902 ↗ |